Bicycle Therapeutics plc Finance Lease, Liability
Bicycle Therapeutics plc (BCYC) had Finance Lease, Liability of $762.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2026-07-30
- 2026-06-30: Finance Lease, Liability $762.00K.
- 2026-03-31: Finance Lease, Liability $811.00K.
- 2025-12-31: Finance Lease, Liability $900.00K; Finance Lease, Liability as first filed $874.00K.
- 2025-09-30: Finance Lease, Liability $939.00K.
| Period end | Finance Lease, Liability | Finance Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $762.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $811.00K 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $900.00K 10-Q · filed 2026-07-30 | $874.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $939.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $988.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $977.00K 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $1.00M 10-K · filed 2026-03-17 | $992.00K 10-K · filed 2025-02-25 |
| 2024-09-30 | $1.10M 10-Q · filed 2024-10-31 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |